Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Osteoarthritis Cartilage ; 16(9): 1047-53, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18359648

ABSTRACT

OBJECTIVE: To determine the effects of exercise and weight loss interventions on serum levels of four biomarkers and to examine if changes in biomarker levels correlate with clinical outcome measures in obese and overweight adults with knee osteoarthritis (OA). METHODS: Serum was obtained at baseline, 6 and 18 months from 193 participants in Arthritis, Diet and Activity Promotion Trial. This was a single-blind 18-month trial with subjects randomized to four groups: healthy-lifestyle (HL), diet (D), exercise (E) and diet plus exercise (D+E). Serum levels of cartilage oligomeric matrix protein (COMP), hyaluronan (HA), antigenic keratan sulfate (AgKS), and transforming growth factor-beta1 (TGF-beta1) were measured by enzyme linked immunosorbent assay. RESULTS: At baseline there were no significant differences in biomarker levels between intervention groups. When results for all the intervention groups were combined, the levels of HA were found to be negatively correlated with medial joint space width and positively correlated with Kellgren-Lawrence scores (K-L scores) while TGF-beta1 levels negatively correlated with K-L scores. When biomarker levels measured at 6 and 18 months were adjusted for baseline values, age, gender, and body mass index, weak but significant differences between intervention groups were present for mean levels of COMP and TGF-beta1. Furthermore, AgKS levels averaged over all groups tended to decrease over time. There were no significant associations of baseline biomarkers and the follow-up outcomes. Weak associations were noted between change in the biomarkers at 18 months and change in outcome measures that included change in weight with AgKS and COMP and change in Western Ontario and McMaster Universities Osteoarthritis Index pain with AgKS. CONCLUSION: Overall, the E and D interventions did not show a consistent effect on levels of potential OA biomarkers. The four biomarkers showed differences in correlations with outcome measures suggesting that they may measure different aspects of disease activity in OA. The strongest correlations were between serum HA and radiographic measures of OA at baseline.


Subject(s)
Extracellular Matrix Proteins/blood , Glycoproteins/blood , Hyaluronic Acid/blood , Keratan Sulfate/blood , Osteoarthritis, Knee/blood , Protein Serine-Threonine Kinases/blood , Receptors, Transforming Growth Factor beta/blood , Aged , Biomarkers/blood , Body Mass Index , Cartilage Oligomeric Matrix Protein , Diet, Reducing , Enzyme-Linked Immunosorbent Assay/methods , Exercise Therapy , Female , Humans , Life Style , Male , Matrilin Proteins , Obesity , Osteoarthritis, Knee/physiopathology , Receptor, Transforming Growth Factor-beta Type I , Time Factors , Weight-Bearing/physiology
2.
Osteoarthritis Cartilage ; 16(1): 1-11, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17631390

ABSTRACT

OBJECTIVE: To examine the effect of beta-aminopropionitrile (BAPN), an inhibitor of lysyl oxidase, on growth and remodeling of immature articular cartilage in vitro. DESIGN: Immature bovine articular cartilage explants from the superficial and middle layers were cultured for 13 days in serum-containing medium with or without BAPN. Variations in tissue size, accumulation of proteoglycan and collagen (COL), and tensile mechanical properties were assessed. RESULTS: The inclusion of serum resulted in expansive tissue growth, stimulation of proteoglycan and COL deposition, and a diminution of tensile integrity. Supplementation of medium with BAPN accentuated this phenotype in terms of a further increase in tissue size in explants from the superficial layer and further diminution of tensile integrity, without affecting the contents of proteoglycan and COL in explants from both the superficial and middle layers. CONCLUSION: COL crosslinking is a major factor in modulating the phenotype of cartilage growth and the associated balance between proteoglycan content and integrity of the COL network.


Subject(s)
Aminopropionitrile/pharmacology , Cartilage, Articular/drug effects , Collagen/metabolism , Proteoglycans/metabolism , Animals , Animals, Newborn , Cartilage, Articular/growth & development , Cartilage, Articular/metabolism , Cattle , Tensile Strength/drug effects , Tensile Strength/physiology
3.
Osteoarthritis Cartilage ; 14(12): 1272-80, 2006 Dec.
Article in English | MEDLINE | ID: mdl-16820306

ABSTRACT

OBJECTIVE: Platelet-rich plasma (PRP) is a fraction of plasma that contains high levels of multiple growth factors. The purpose of this study was to examine the effects of PRP on cell proliferation and matrix synthesis by porcine chondrocytes cultured in alginate beads, conditions that promote the retention of the chondrocytic phenotype, in order to determine the plausibility of using this plasma-derived material for engineering cartilage. DESIGN: PRP and platelet-poor plasma (PPP) were prepared from adult porcine blood. Adult porcine chondrocytes were cultured in the presence of 10% PRP, 10% PPP or 10% fetal bovine serum (FBS) for 3 days. Cell proliferation, proteoglycan (PG) and collagen synthesis were quantified, and the structure of newly synthesized PG and collagen was characterized. RESULTS: Treatment with 10% PRP resulted in a small but significant increase in DNA content (+11%, vs FBS; P<0.01; vs PPP; P<0.001). PG and collagen syntheses by the PRP-treated chondrocytes were markedly higher than those by chondrocytes treated by FBS or PPP (PG; PRP: +115% vs FBS; +151% vs PPP, both P<0.0001, collagen; PRP: +163% vs FBS; +163% vs PPP, both P<0.0001). Biochemical analyses revealed that treatment with PRP growth factors did not markedly affect the types of PGs and collagens produced by porcine chondrocytes, suggesting that the cells remained phenotypically stable in the presence of PRP. CONCLUSION: PRP isolated from autologous blood may be useful as a source of anabolic growth factors for stimulating chondrocytes to engineer cartilage tissue.


Subject(s)
Blood Platelets/physiology , Cartilage, Articular/cytology , Chondrocytes/cytology , Plasma/cytology , Alginates , Animals , Cartilage, Articular/metabolism , Cell Culture Techniques , Cell Proliferation , Chondrocytes/metabolism , Collagen/biosynthesis , DNA/biosynthesis , Extracellular Matrix/metabolism , Glucuronic Acid , Hexuronic Acids , Microspheres , Platelet Count , Proteoglycans/biosynthesis , Swine , Swine, Miniature , Transforming Growth Factor beta/blood
4.
Osteoarthritis Cartilage ; 14(4): 384-91, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16324853

ABSTRACT

OBJECTIVE: This study examined the effects of a growth factor, recombinant human osteogenic protein-1 (rhOP-1), on the formation of tissue-engineered cartilaginous tissue by adult bovine articular chondrocytes using the alginate-recovered-chondrocyte (ARC) method. DESIGN: To ascertain if rhOP-1 enhances the formation of the cell-associated matrix (CM) and the characteristics of CM formation, bovine articular chondrocytes were first cultured for up to 14 days in alginate beads in medium supplemented with serum, with or without rhOP-1. Then, the recovered chondrocytes and their associated CM were resuspended in medium, with or without OP-1, seeded onto culture inserts, and incubated for an additional 14 days. The fabricated ARC tissues were subjected to biochemical and histological analyses. RESULTS: The addition of rhOP-1 to the medium in the alginate bead culture step resulted in an increased accumulation of both proteoglycan (PG) and collagen, with a ratio of PG to collagen that was higher than that found in native adult cartilage. The addition of rhOP-1 in the second step had a similar stimulatory effect during 14 days of culture. Histological examination of the tissue formed under all conditions revealed a cartilage-like matrix, stained strongly by toluidine blue. The thickness of the tissues obtained from culture conditions that included the addition of rhOP-1 was four times greater than that of the tissues cultured without rhOP-1. CONCLUSIONS: Using the ARC method, rhOP-1 enhanced the formation of matrix and generated a voluminous tissue-engineered cartilaginous construct. These characteristics may be beneficial in generating constructs that can cover large defects.


Subject(s)
Bone Morphogenetic Proteins/pharmacology , Cartilage, Articular/cytology , Chondrocytes/cytology , Tissue Engineering/methods , Transforming Growth Factor beta/pharmacology , Alginates , Animals , Biocompatible Materials , Bone Morphogenetic Protein 7 , Cartilage, Articular/chemistry , Cattle , Cell Culture Techniques/methods , Collagen/chemistry , Extracellular Matrix/chemistry , Glucuronic Acid , Hexuronic Acids , Proteoglycans/chemistry
5.
Osteoarthritis Cartilage ; 11(8): 595-602, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12880582

ABSTRACT

OBJECTIVE: To test if subpopulations of chondrocytes from different cartilage zones could be used to engineer cartilage constructs with features of normal stratification. ESIGN: Chondrocytes from the superficial and middle zones of immature bovine cartilage were cultured in alginate, released, and seeded either separately or sequentially to form cartilage constructs. Constructs were cultured for 1 or 2 weeks and were assessed for growth, compressive properties, and deposition, and localization of matrix molecules and superficial zone protein (SZP). RESULTS: The cartilaginous constructs formed from superficial zone chondrocytes exhibited less matrix growth and lower compressive properties than constructs from middle zone chondrocytes, with the stratified superficial-middle constructs exhibiting intermediate properties. Expression of SZP was highest at the construct surfaces, with the localization of SZP in superficial-middle constructs being concentrated at the superficial surface. CONCLUSIONS: Manipulation of subpopulations of chondrocytes can be useful in engineering cartilage tissue with a biomimetic approach, and in fabricating constructs that exhibit stratified features of normal articular cartilage.


Subject(s)
Cartilage, Articular/physiology , Chondrocytes/physiology , Tissue Engineering/methods , Animals , Blotting, Western/methods , Cattle , Cells, Cultured , Enzyme-Linked Immunosorbent Assay/methods , Extracellular Matrix/physiology , Hindlimb , Immunohistochemistry/methods , Proteoglycans/analysis , Stress, Mechanical
6.
Osteoarthritis Cartilage ; 10(3): 226-33, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11869084

ABSTRACT

OBJECTIVE: The purpose of this work was to test the effect of inhibition of bone remodeling, through the use of the bisphosphonate, zoledronic acid, on cartilage matrix damage in an animal model of cartilage matrix damage. DESIGN: New Zealand white rabbits were divided into four groups for treatment purposes: (1) untreated controls; (2) injected into one knee joint with the cartilage matrix degradation enzyme, chymopapain; (3) injected into one knee joint with chymopapain and also given subcutaneous injections of the bisphosphonate, zoledronic acid, three times per week until sacrifice at either day 28 or 56 post-chymopapain-injection; (4) received only the zoledronic acid injections. At sacrifice, the knee joints were examined grossly and histologically, and biochemically for proteoglycan content. Urine samples were analysed, at intervals, for levels of collagen cross-links which are biochemical markers of cartilage and bone. RESULTS: Animals receiving both intraarticular chymopapain injections and subcutaneous zoledronic acid injections displayed a significantly lower degree of grossly and histologically detectable cartilage degeneration on the tibial articular surfaces (the articular surface displaying the greatest degree of degeneration) than did animals only receiving the chymopapain injections. In addition, urinary levels of collagen cross-links for bone and cartilage were significantly higher in those animals only receiving chymopapain injections. CONCLUSION: The bone resorption observed after chymopapain injection into the rabbit knee joint can be inhibited through the use of the bisphosphonate, zoledronic acid. Furthermore, zoledronic acid does not increase the level of cartilage degeneration and appears to provide some level of chondroprotection in this model.


Subject(s)
Bone Remodeling/drug effects , Cartilage Diseases/chemically induced , Diphosphonates/adverse effects , Imidazoles/adverse effects , Animals , Biomarkers/urine , Cartilage, Articular/metabolism , Chymopapain/adverse effects , Collagen/urine , Hindlimb , Joints , Male , Models, Animal , Osteoarthritis/chemically induced , Proteoglycans/chemistry , Rabbits , Zoledronic Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...